Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2020 Annual Meeting | C244 - Cognitive Impairment Due to Alzheimer's Disease: Using Old Skills and New Tools for Diagnosis and Treatment

Thursday 04/30/20
03:30 PM - 05:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Seminar
David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­
Aging, Dementia, and Behavioral Neurology
Participants should develop an enhanced appreciation of the limits of sensitivity specificity of the diagnosis of Alzheimer's disease as an etiology of cognitive impairment.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Intermediate
Advanced Practice Provider
Fellow, General Neurologist
Case-based, Didactic
Event Timeline
03:30 PM - 04:00 PM Speaker Clinical Diagnosis of Alzheimer Disease
Richard J. Caselli, MD, FÂ鶹´«Ã½Ó³»­
04:00 PM - 04:25 PM Speaker Biomarkers in the Diagnosis of Alzheimer Disease
David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­
04:25 PM - 04:50 PM Speaker Clinical Genetics of Alzheimer Disease
Richard J. Caselli, MD, FÂ鶹´«Ã½Ó³»­
04:50 PM - 05:15 PM Speaker Status of Therapeutics in Alzheimer Disease
David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
David S. Knopman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Richard J. Caselli, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Caselli has received research support from NIA. The institution of Dr. Caselli has received research support from State of Arizona.